Why Investors Should Stick to Beam Therapeutics Inc (NASDAQ: BEAM) Stock in 2025
In the last trading session, 1.53 million Beam Therapeutics Inc (NASDAQ:BEAM) shares changed hands as the company’s beta touched 2.08. With the company’s per share
In the last trading session, 1.53 million Beam Therapeutics Inc (NASDAQ:BEAM) shares changed hands as the company’s beta touched 2.08. With the company’s per share
In last trading session, Beam Therapeutics Inc (NASDAQ:BEAM) saw 1.29 million shares changing hands with its beta currently measuring 2.08. Company’s recent per share price
In today’s recent session, 1.05 million shares of the Beam Therapeutics Inc (NASDAQ:BEAM) have been traded, and its beta is 2.08. Most recently the company’s
Beam Therapeutics Inc (NASDAQ:BEAM) has a beta value of 2.10 and has seen 2.29 million shares traded in the last trading session. The company, currently
In the last trading session, 1.33 million shares of the Beam Therapeutics Inc (NASDAQ:BEAM) were traded, and its beta was 2.16. Most recently the company’s
Beam Therapeutics Inc (NASDAQ:BEAM)’s traded shares stood at 1.33 million during the last session, with the company’s beta value hitting 2.14. At the close of
© 2024, Powered by Smart TechOne